Objectives: Our goal was to develop and validate, based on theoretical and empirical knowledge, the Pain Assessment Checklist for Seniors with Limited Ability to Communicate (PACSLAC-II), a shorter tool that would improve on the PACSLAC, while addressing limitations of the original version.
P ain is a subjective experience. Effective communication between the individual in pain and the observer is necessary for the optimization of assessment and treatment. Because of its subjective nature, pain is usually assessed through self-report. However, for an older person with dementia and his or her caregivers, the process of pain communication is complicated by the cognitive and verbal impairments that accompany dementia. Indeed, research has confirmed that older persons with dementia are less able to identify the location or rate the intensity of their pain compared with cognitively intact counterparts. 1, 2 From the caregiver's perspective, assessing and managing the pain of older persons with dementia is also a great challenge. Specifically, long-term care (LTC) nurses report having difficulty accurately identifying pain in their residents with dementia. 3 Barriers in pain communication for older persons with dementia and their caregivers are likely contributors to the undermanagement of pain in this population. [4] [5] [6] [7] [8] To address the undermanagement of pain, the past decade saw the development of numerous observational pain assessment tools for more systematic identification of pain in older persons with dementia. [9] [10] [11] Some of the most highly rated tools include the Pain in Advanced Dementia (PAINAD), 12 DOLOPLUS-II, 13 and the Pain Assessment Checklist for Seniors with Limited Ability to Communicate (PACSLAC). 14 Although all 3 of these tools were shown to have satisfactory psychometric properties, the PACSLAC was rated as the most clinically useful of the 3 by the nursing staff. 15 Moreover, in a direct psychometric comparison of some of the most widely used scales for older persons with dementia, the PACSLAC was shown to account for the most variance in ability to differentiate pain-related from non-pain-related states. 16 Studies have also suggested that consistent use of the PACSLAC can lead to improved pain management practices. 17, 18 Finally, the PACSLAC is the only tool of its kind that comprehensively covers all 6 domains of nonverbal behaviors deemed to be important for pain assessment in this population by the American Geriatric Society ([AGS] ie, facial expressions, verbalizations and vocalizations, body movements, changes in activity patterns and routines, changes in interpersonal interactions, and mental status changes). 19 Although the PACSLAC has demonstrated the aforementioned strengths, issues that have been raised in the literature about pain assessment of the older adult, which led us to conclude that PACSLAC could be improved further. According to Smith and McCarthy, 20 test refinement should occur when the constructs measured have become better understood thus making improved measurement possible. 21 In the case of observational pain assessment in older adults with dementia, recent research on behavioral indicators of pain suggest that improvement in pain identification could be possible by taking into account current knowledge (eg, minimize pain assessment tool item overlap with delirium, use of well-defined facial actions associated with pain). Specifically, in developing a revised PACSLAC, we aimed to address the following concerns.
(1) Although the PACSLAC normally requires <5 minutes to complete, with its 60 items, it remains one of the longest assessment tools of its kind. Given resource limitations and documentation challenges that may occur in LTC facilities, 22 it was felt that a shorter tool would facilitate efficiency and documentation. A goal was to retain coverage of the AGS pain assessment domains in the shorter tool. (2) Most pain assessment tools for seniors with dementia contain items that overlap with conditions that are not necessarily pain-related (eg, delirium) and this may make pain assessment more challenging. 23 Moreover, initial investigation of this issue suggested that deletion of PACSLAC items, which are highly overlapping with symptoms of delirium, does not seem to have a significant negative impact on its psychometric properties. 16 In revising the PACSLAC, our goal was to eliminate items that were most likely to overlap with delirium. (3) Finally, it has been observed that certain PACSLAC items (eg, dirty look) were vague 24 and that specific facial-behavioral actions shown to characterize the pain experience, were not included in the PACSLAC (eg, lowered brow, raised cheek). 25, 26 It is important to note that such facial actions have been observed in older persons with dementia when experiencing pain. [27] [28] [29] This investigation was conducted in 3 phases: (1) revision of the PACSLAC based on theoretically and empirically driven modification of the items; (2) examination of the psychometric properties of the resulting PAC-SLAC-II using archival footage of LTC residents of undergoing painful procedures; and (3) use of the PACSLAC and PACSLAC-II in LTC facilities by nurses and care aides who then provided feedback about each tool.
As part of the examination of the psychometric properties of the PACSLAC-II, our goal was to compare its psychometric properties and ability to differentiate between pain and nonpain states against the PACSLAC and other observational pain assessment tools (ie, Checklist of Nonverbal Pain Indicators [CNPI] 30 32 ). It was hypothesized that the PACSLAC-II would demonstrate: (1) improved ability to differentiate painful from nonpainful states (compared with the PAC-SLAC); (2) significant positive correlation with other pain assessment tools for seniors with dementia; (3) lack of significant correlation with a non-pain-related measure assessing depression; and (4) ability to discriminate between pain and baseline conditions while controlling for the contribution of other measures (ie, CNPI, NOPPAIN, PACSLAC, PADE, PAINAD). Following the psychometric evaluation, we sought the opinions of front-line staff who were asked to use either the PACSLAC or the PACSLAC-II in their day-to-day practice.
METHODS

Participants
Video-taped Pain Expressions
We used videos of 124 residents from 4 LTC facilities. 16 As described by Lints-Martindale et al, 16 study information was sent out by the LTC facilities to proxies or legal guardians of the residents to obtain proxy consent. Resident assent was sought in all cases. Of the 124 residents, 85 were filmed for both a needle injection and movement-exacerbated pain conditions. Fifteen residents were filmed only during needle injection and 24 were filmed only during movement-exacerbated pain, resulting in a total of 100 residents filmed for needle injection and 109 for movement-exacerbated pain. The sample consisted of 88 females (71%) and 36 males (29%). The average age of the sample was 83.94 (SD = 7.95, range = 61 to 101). The average Mini Mental Status Examination (MMSE) 33 score of LTC residents was 5.35 (SD = 7.72, range = 0 to 26), indicating that on average the residents lived with a severe level of cognitive impairment. The average number of medical diagnoses for the LTC residents was 5.39 (SD = 2.28, range = 1 to 12; eg, Alzheimer disease, vascular dementia, osteoporosis, glaucoma, arthritis).
Use in LTC
Twenty-six LTC staff completed either the PACSLAC or PACSLAC-II (see the Procedure section). Informed consent was obtained from all participants. Most participants were female (n = 25), with an average age of 47.6 years (SD = 9.6) and had worked in the LTC field for about 16.5 years (SD = 10.0). Of the 26 participants, 14 (ie, 9 nurses, 5 care aides) used the PACSLAC and 12 (ie, 7 nurses, 5 care aides) used the PACSLAC-II. No patient data were collected by the researchers in this phase of the study.
Measures
MMSE 33
MMSE is a brief tool designed to indicate the presence and level of cognitive impairment. It consists of questions focused on determining cognitive functioning in various categories: orientation to time and place, registration and recall, attention and calculation, language, and visual construction. The MMSE is used frequently with LTC patients with dementia and has been found to have good psychometric properties with this population. 34, 35 Cornell Scale for Depression in Dementia (CSDD) 36 CSDD is a tool designed to assess depression in adults with mild to severe dementia. The 19-item scale requires the caregiver to rate symptoms of depression based on the week before the interview (ie, a = unable to evaluate, 0 = absent, 1 = mild or intermittent, 2 = severe). CSDD has been found to have good psychometric properties. 36, 37 0.66). The CNPI has shown strong correlation with the visual analogue scale scores by the same rater, and moderate correlation between 2 different raters. 38 For the present sample, the CNPI showed high interrater reliability (k = 0.93) and lower level of internal consistency (a = 0.51 and.47) during needle injection and movement-exacerbated pain. 16 
PADE 31
PADE is a 24-item scale designed to assess 3 areas: (1) observable pain indicators; (2) rating of pain intensity; and (3) chart review of the resident's activities of daily living. As the observational indicators of pain are contained in part 1 of the scale (eg, facial expressions, breathing patterns, postures), only this part was used in the present study. Part 1 of the PADE assesses 5 of the 6 AGS behavioral domains. The PADE has demonstrated acceptable to good internal consistency (a = 0.77 to 0.88), strong interrater reliability (r = 0.93 to 0.95), and strong test-retest reliability (r = 0.70). Completion time for the PADE is longer compared with other scales due to complexity of item and response style. For the present sample, part 1 of the PADE showed substantial interrater reliability (k = 0.71) and lower levels of internal consistency (a = 0.13 and 0.27) during needle injection and movement-exacerbated pain. 16 
PAINAD 12
PAINAD is a 5-item scale designed to measure breathing, negative vocalizations, facial expression, body language, and consolability in individuals with advanced dementia. Observers rate each behavior on a scale of 0 to 2, where 0 represents normal functioning and 2 represents behaviors hypothesized to indicate pain (eg, noisy labored breathing, loud moaning or groaning, facial grimacing, rigid, or unable to console). The PAINAD can be completed within a few minutes. Previous studies have shown that the PAINAD has good internal consistency (a = 0.69 to 0.85), strong interrater reliability (r = 0.75 to 0.97), and strong test-retest reliability (r = 0.88 to 0.90). 15, [39] [40] [41] PAINAD has been shown to correlate well with observer pain ratings and other observational pain tools (r = 0.81 to 0.85), 15 and poorly with the CSDD. 42 For the present sample, the PAINAD showed high interrater reliability (k = 0.87) and acceptable internal consistency (a = 0.78 and 0.73) during needle injection and movement-exacerbated pain. 16 
NOPPAIN 32
The NOPPAIN is a pain screening tool designed for nursing assistants to observe and assess for pain in residents with dementia. The tool consists of 4 main parts. In part 1, the rater notes the presence or absence of pain in 9 care activities (eg, turned resident in bed, dressed resident, bathed resident). For the purposes of this study, observers were asked to indicate what kind of activity was observed (ie, at rest, administration of influenza vaccinations, or movement-related activities). In part 2, the rater notes the presence or absence of specific pain indicators and rate the intensity of the observed pain response on a scale of 0 to 5 (ie, pain words, pain faces, bracing, pain noises, rubbing, and restlessness). Part 3 involves marking the location of pain and skin problems in residents. Interrater reliability was found to be moderate to strong, and intrarater consistency over time was also found to be good to very good. 43 The NOPPAIN has been found to correlate with coding of pain behaviors from videos. 32 It requires <1 minute to complete once care activities are conducted. 43 For the present sample, substantial interrater reliability was found (k = 0.73), but lower internal consistency was found (a = 0.41 to 0.48) during both movement-exacerbated pain and needle injection pain conditions. 16 Procedure Revision of the PACSLAC Figure 1 shows the modifications that were made on the PACSLAC. The PACSLAC-II items have also been included in the figure.
We initially utilized the nonverbal pain assessment domains of the AGS (ie, facial expressions, verbalizations and vocalizations, body movements, changes in activity patterns and routines, changes in interpersonal interactions, and mental status changes) to organize the PACSLAC and PACSLAC-II items (Fig. 1 ). The AGS domains formed the basis for conceptually organizing the PACSLAC-II items. We then deleted PACLSAC items that have been previously identified 16 as being most likely to overlap with delirium. We then added specific pain behaviors that were identified in previous research 25, [44] [45] [46] as being pain specific (eg. wrinkled nose, raised upper lip, guarding, rubbing the sore area). Finally, we added an item inquiring about mental status changes that are likely to be the result of pain to retain coverage of all AGS domains. The resulting items are shown in Figure 1 . As is the case with the PACSLAC, PACSLAC-II items are scored as 0 or 1 to indicate whether or not a given behavior was observed at least once.
Application on Archival Video Footage
Archival video footage of LTC residents with dementia undergoing painful procedures, previously recorded as part of a study comparing observational pain assessment tools was used. 16 As reported by Lints-Martindale et al, 16 participants were filmed under 4 conditions which were part of routine care for LTC residents and included (1) needle injection of the annual influenza vaccination (ie, acute phasic pain); (2) movement-exacerbated pain through activities that were believed by nursing staff to be painful/ discomforting for a given patient (eg, transfers, physiotherapy, range of motion exercises); (3) a baseline segment of the participant at rest before the needle injection or movement/activity; and (4) a control (ie, nonpain induction) segment depicting the participant during swabbing done to cleanse the skin before the needle injection. Video segments were edited such that movement-exacerbated pain and baseline footage were equal in length (ie, 2 equally long segments in total), and needle injection, swabbing, and baseline (corresponding to the needle injection) footage were also equal in length (ie, 3 equally long segments in total). Residents in the video segments were identified only by a participant number and every effort was made to protect their privacy and dignity.
A trained research assistant blind to the hypotheses of the study then viewed the video clips in a randomized order and completed the PACSLAC-II. A second coder also independently viewed and completed the PACSLAC-II for a randomly selected 20% of the video clips to establish interrater reliability. Data collected by Lints-Martindale et al 16 using the PACSLAC, CNPI, NOPPAIN, PADE, PAINAD, based on the same video, were available for comparison purposes. Archival nurse ratings of resident depression CSDD 36 were also available, along with MMSE 33 scores administered by trained research assistants. MMSE scores were used for sample description purposes.
Use in LTC
LTC staff, unfamiliar with the PACSLAC and the PACSLAC-II, were randomly assigned to use either the PACSLAC or the PACSLAC-II for a period of 4 to 6 weeks, with up to 3 of their LTC residents with moderate to severe dementia, at least 3 times each week (per patient). Instructions on how to use the tool appropriately was provided by one of the researchers. Pain scores were recorded on the tool itself and on a pain graph to facilitate tracking of pain scores. These scores were used strictly for clinical purposes and no patient data were collected for the purposes of this research. Following the 4-to 6-week period of using the tool, staff participants were interviewed for about 30 minutes, using a semistructured format regarding the clinical usefulness, and benefits and challenges of using the tool. Staff participants were also shown the version of the tool that they were not assigned to use, asked to make comments on it, and to state a preference for which version of the tool they would prefer to use. Staff participants then responded to 5 questions (see Table 1 ) about the clinical utility of the version of the tool they were assigned. Sixpoint Likert scales were used to record the nurses' responses to these questions.
RESULTS
Quantitative Examination of the PACSLAC-II
Reliability
Cronbach a statistics showed that the PACSLAC-II had satisfactory 47 internal consistency in the pain conditions (a = 0.77 influenza vaccination, a = 0.74 movement-exacerbated pain). Cohen k was also calculated and showed that the PACSLAC-II demonstrated satisfactory 48 interrater reliability (k = 0.63). Table 2 shows the convergent and discriminant validity correlations. Convergent validity was determined by examining the relationships between the PACSLAC-II and other pain assessment tools. As expected, the PACSLAC-II significantly correlated with all pain tools in the influenza vaccination, swabbing, and movement-exacerbated pain conditions. PACSLAC-II scores showed the strongest correlation with PACSLAC (r[98] = 0.89, P < 0.01 influenza vaccination; r[108] = 0.81, P < 0.01 movement-exacerbated pain), and the NOPPAIN (r[93] = 0.73, P < 0.01 swabbing). Discriminant validity was determined by examining the relationship between the PACSLAC-II and the CSDD ( Table 2 ). As expected, the PACSLAC-II was not significantly correlated with the CSDD.
Validity
PACSLAC-II to discriminate between baseline and pain states was tested by conducting 2 within-subjects repeated measures analyses of variance: (1) baseline (ie, a control segment) versus swabbing (the swabbing phase was intended as a non-pain-related control segment) versus vaccination; (2) baseline versus movement-exacerbated pain. The PACSLAC-II differentiated between control and pain segments, for the vaccination condition, F 2,92 = 80.92, P < 0.001, partial Z 2 = 0.64; and for the movement-exacerbated pain condition F 1,105 = 118.02, P < 0.001, partial Z 2 = 0.53. Paired comparisons showed that PACSLAC-II means for baseline, swabbing, vaccination differed significantly P < 0.01.
An analysis of covariance (ANCOVA), with 4 repeated measures, was conducted to determine whether the PACSLAC-II can differentiate across both types of painrelated conditions (baseline vs. swabbing vs. vaccination vs. movement-exacerbated pain). Video segment time in seconds was entered as a covariate to account for different clip lengths (ie, although, as indicated earlier, all segments related to the needle injection [baseline, swabbing, and needle injection] were edited to be of equal length, the length of these 3 segments was not necessarily equal to the length of the movement-exacerbated pain segment). The ANCOVA yielded statistically significant results, F 3,73 = 5.32, P < 0.001, partial Z 2 = 0.07. Follow-up comparisons, using Bonferroni adjustment to guard against type I error, were conducted. These are summarized in Table 4 .
Comparisons With Other Observational Pain Tools
To compare the PACSLAC-II's ability to discriminate between pain and baseline to that of the other observational pain tools that were studied by Lints-Martindale et al, 16 effect sizes (partial Z 2 ) were examined ( Table 5 ). Among all pain tools (ie, CNPI, NOPPAIN, PACSLAC-II, PAC-SLAC, PADE, PAINAD), the PACSLAC-II demonstrated the highest effect sizes in both the influenza vaccination and movement-exacerbated pain conditions.
Controlling for Contribution from Other Pain Tools
Another method of examining a tool's unique ability to discriminate between pain and nonpain states was to conduct a series of ANCOVAs while taking into account the contribution of other pain tools. 16 Consistent with Lints-Martindale et al, 16 this analysis was conducted by entering as covariates the difference scores of all other pain tools (eg, PAINAD difference score for vaccination = PAINAD influenza vaccination score ÀPAINAD baseline score). Difference scores indicate the amount of variance measured by each assessment instrument from the baseline to the pain condition. 49, 50 If the analysis becomes nonsignificant once the covariates are added, it would indicate that other pain tools together account for a greater part of the variance than the PACSLAC-II alone. However, if the analysis remains significant, this would indicate that the pain tool accounts for greater variance than all of the other pain tools combined.
Results indicated that the PACSLAC-II was able to differentiate between pain and baseline in both the movement-exacerbated pain and the vaccination conditions, while controlling for variance accounted for by all other tools. First, when difference scores of the CNPI, NOP-PAIN, PAINAD, and PADE were entered as covariates, PACSLAC-II was able to differentiate between baseline and pain during the vaccination F 1,93 = 32.01, P < 0.001, partial Z 2 = 0.26; and movement-exacerbated pain conditions, F 1,101 = 29.04, P < 0.001, partial Z 2 = 0.22. (When examining these two effect sizes of 0.22 and 0.26, it is important to note, for the purposes of comparison with Lints-Martindale et al, 16 that the Lints-Martindale and colleague's study also included as a covariate number of pain behaviors from the Assessment of Discomfort in Advanced Dementia [ADD] protocol. [51] [52] [53] The ADD behaviors were not included in this investigation because the ADD is not a standardized assessment checklist per se. Nonetheless, we conducted a parallel ANCOVA that included the ADD as a covariate but this did not have any substantive effect on the partial Z 2 values obtained without the ADD [ie, the corresponding Z 2 values with the ADD included were 0.24 for vaccination and 0.21 for movement pain]. When PACSLAC difference scores were also included with other tools as covariates, the PACSLAC-II retained its ability to differentiate between pain and baseline, during the vaccination F 1,92 = 26.97, P < 0.001, partial Z 2 = 0.23; and movement-exacerbated pain condition F 1,100 = 17.65, P < 0.001, partial Z 2 = 0.15. Nonetheless, the addition of PACSLAC difference scores led slight decreases in effect sizes, which is expected due to the similarities across the PACSLAC and PACSLAC-II.
Ratings from LTC Staff
Staff ratings on clinical utility of the tool they used are summarized in Table 1 . These ratings were subjected to statistical comparison. That is, the ratings of the PAC-SLAC users were compared with those of the PACSLAC-II users. T tests did not yield any significant differences. It is also noted that participants were instructed to complete the PACSLAC or PACSLAC-II for up to 3 residents with dementia at least 3 times a week. The overwhelming majority of participants completed it for 3 residents each, 2 participants completed it for 2 residents each, and 2 completed it for only 1 resident each.
Qualitative Examination of PACSLAC-II Use
Interviews were transcribed and coded using QSR NVivo 8.0 software and analyzed using thematic analysis. 54, 55 The coding structure was created by discussions between 2 of the researchers with the aim of addressing whether and why the participant preferred the PACSLAC or PACSLAC-II and whether and how the pain tools were clinically useful to the participant. Coded data were examined comparing each group (ie, participants who used the PACSLAC vs. those who used the PACSLAC-II). To ensure trustworthiness of the coding (ie, that the findings are credible, dependable, and transferable) 56 a research assistant, not previously involved in the qualitative analysis, categorized a randomly selected 20% of the data. Agreement of 84% was found. Upon completion of analyses, member checking was conducted for a randomly selected 20% of participants to ensure accurate interpretation of feedback. 55, 57 Members were asked to review a summary of key findings and provide a rating using a 7-point Likert scale regarding the accuracy of the researcher's interpretation of the interview data. Member check ratings indicated a mean agreement rating of 5.67/7.0, SD = 0.82, reflecting strong but not perfect agreement. This was expected as summaries of findings took into account all feedback and not only feedback from any 1 individual interview.
A majority of those who used the original PACSLAC (ie, 11 of 14 participants) stated that they preferred the PACSLAC-II when they were shown the revised tool. In contrast, for participants who used the PACSLAC-II, when shown the original PACLSAC, about half the participants stated that they preferred the original and the other half the PACSLAC-II. Analyses of interview data revealed that participants viewed both the PACSLAC and PACSLAC-II as clinically useful tools but that each tool offered unique advantages to pain assessment. The PACSLAC-II was viewed as a brief tool that fit within a focused approach to pain assessment, whereas the original PACSLAC was more detailed and participants stated that it may provide a more comprehensive assessment. Specifically, for the PACSLAC-II, participants felt that it was more concise, which promoted documentation and memorization of the pain behaviors, which they felt may lead to greater efficiency in pain assessment and control for their residents.
So this would be a good tool to work for med control for pain control, because it would get us to learn about the residents faster, and their aches and pains faster, and their pain control faster. (Care aide, used PACSLAC-II)
In contrast, participants viewed the original PAC-SLAC as a more comprehensive tool that called the caregiver's attention to a greater range of behaviors, which may signal pain as well as other problems, thus fitting within a more general observational assessment of the resident.
I paid more attention to them and to why they're acting that way. And then I noticed that with the one guy, when he started getting headaches is when he started getting agitated and upset and wanting to go home and more confused, so it kinda all came together. (Nurse, used PACSLAC)
Staff reported that both tools contributed to enhancing the participants' practice by increasing awareness of pain behaviors, promoting more careful observations of residents, increasing awareness of resident pain patterns, as well as changing pain management practices and communication amongst nurses, aides, and physicians.
DISCUSSION
Development and Validation
We developed a new, briefer version of the PACSLAC, the PACSLAC-II, based on the empirical and theoretical literature. We demonstrated that the PACSLAC-II has satisfactory psychometric properties including improved ability to differentiate between pain-related and baseline segments when compared with the PACSLAC and other preexisting tools. Moreover, as hypothesized, not only did the PACSLAC-II discriminate between pain and non-painrelated states but also accounted for unique variance over and above the contribution of all other tools combined, including the PACSLAC. This suggests that eliminating items overlapping with delirium, and adding more painspecific items (eg, specific facial actions) led to greater ability to discriminate between pain and nonpain states. It is also possible that reduction of length and reorganization of items into the 6 AGS-recommended domains (eg, facial expressions, verbalizations and vocalizations, body movements) facilitated the process of identifying pain behaviors.
To determine the extent to which deletion of items most related to delirium accounted for the improved validity, results of this investigation could be compared with results obtained by Lints-Martindale et al, 16 who examined the original PACSLAC excluding delirium-related items but without the addition of any new items. Analyses testing the differentiation of pain versus baseline while taking into account the contribution of other tools (ie, ANCOVAs) show that the effect sizes of the PACSLAC-II are greater than those of the PACSLAC with delirium-items removed (ie, PACSLAC-II partial Z 2 > 0.23 vaccination condition, partial Z 2 > 0.20 movement-exacerbated pain condition, compared with PACSLAC partial Z 2 = 0.01 vaccination condition, partial Z 2 = 0.02). Arguably, the PACSLAC-II was able to account for a greater proportion of the variance compared with the original PACSLAC without deliriumrelated items. This indicates that removing delirium-related items alone from the original PACSLAC did not lead to all of the improvements in psychometric properties observed in this study. That is, there were more factors (presumably the clearer pain-specific items) that accounted for the superior ability of the PACSLAC-II to discriminate between pain and non-pain-related states.
The finding that the revision of items led to improved ability to discriminate pain from baseline states has significant implications. As mentioned in previous studies, 16 many observational pain assessment tools consist of items that overlap with other conditions such as delirium and depression. 23 Although these items (eg, agitation) may on the surface appear to facilitate pain detection since the behaviors in question occur during pain states (although they are not unique to pain), the findings of this study suggest that elimination of such items does not decrease the tool's ability to discriminate between pain and nonpain states. Further, the potential appropriateness of shortening the pain checklist by removing delirium-related items is also significant with respect to clinical utility, in that this may reduce the burden of paperwork and time needed for assessment, thus making it more likely that pain management for residents with dementia would be successful.
Front-Line LTC Use
To examine front-line staff impressions about the tool, this investigation involved feedback from LTC staff who used the PACSLAC or the PACSLAC-II with their residents with dementia. It was anticipated that, based on the reduction and modification of items, LTC staff would prefer the PACSLAC-II over the original version. Indeed, many LTC nurses and care aides preferred the PACSLAC-II because of its length and condensed nature, which in their view may promote documentation and greater efficiency in pain assessment and management. Although the quantitative utility and related ratings ( Table 1 ) did not yield preference differences for either the PACSLAC nor the PACSLAC-II, more specific information was derived from the qualitative analysis of the interview transcripts. The qualitative analysis suggested that staff viewed the PACSLAC-II as consistent with a more focused approach to pain assessment where staff used the tool to identify increases and decrease in pain after medication and resident care changes (eg, seating). Other benefits for using the PACSLAC-II, as well as the PACSLAC, were also reported. However, some nurses and care aides reported preference for the original PACSLAC. Specifically, they expressed that they favored the PACSLAC because it provided a greater range of options for describing possible pain, which helped them rule out pain as an underlying cause of observed resident behaviors. This advantage, in their view, also outweighed its relatively longer format. Thus, it appeared that the PACSLAC may represent for nurses and care aides a more comprehensive and open approach to pain assessment which may possibly be most appropriate for training of new staff. Despite this staff impression, the psychometric examination of the tools indicated that the shorter version had better discriminative properties.
Future Directions
It has been suggested that pain assessment in LTC should be regular and individualized 58 and that this can be accommodated using minimal extra resources. 59 It is hoped that the refinement of the PACSLAC accomplished in this investigation will make the PACSLAC-II easier to implement due to its reduced length and improved validity. As indicated by the front-line staff feedback, an advantage of a briefer tool is that it may lead to greater efficiency in pain assessment and management, which would ultimately improve the quality of life of LTC residents with dementia. Nonetheless, more research is needed. In the first instance, it would also be necessary to collect PACSLAC-II data to determine its reliability and validity when used directly by LTC staff outside the scientific laboratory and in situations involving different types of pain (eg, headache, tooth pain). In addition, feedback from front-line staff who used the PACSLAC and the PACSLAC-II for large numbers of residents should also be solicited to evaluate the generalizability of staff opinions obtained through the present research. Study of the PACSLAC-II in acute care settings would also be important to pursue. Moreover, it would be important to encourage further validation work by other research teams.
Although the question of cut-off scores is often raised when evaluating observational pain tools for seniors with dementia, we recommend against cut-off scores at this time. That is, dementia represents very diverse types of damage to the brain with some types of dementia potentially leading to increased responsiveness to pain (eg, dementias primarily affecting the frontal lobe) versus less pronounced responsiveness in other dementias. 60 Therefore, to assume that a single cut-off score would be suitable for all people regardless of dementia type and severity would be problematic. Moreover, scores on these types of scales may be affected by type of pain and duration of observation (eg, the longer periods would likely result in higher scores) that would also make the use of cut-off scores problematic. As well, an individual who normally exhibits many behaviors would likely have a higher baseline score compared with an individual who is more contracted and has limited movement. This range of scores in baseline makes it difficult to establish that a certain cut-off score would imply a certain level of pain for most individuals with dementia. At the present time, the approach that is recommended for pain assessment in older persons with dementia is an individualized one and involves regular pain assessments. In other words, pain assessment should be ongoing (and conducted under similar conditions over time) in LTC facilities. 61 Using regular assessment, pain would be indicated based on deviations from the individual's normal pattern of scores rather than comparing the individual's score to others' in the population. 61 
CONCLUSIONS
This study was aimed at revising a well-established, psychometrically valid tool, the PACSLAC. The resultant PACSLAC-II has demonstrated positive psychometric properties and in particular the ability to differentiate between pain and nonpain states over and above other tools of its kind, including the original PACSLAC. LTC staff who used the PACSLAC-II and PACSLAC also report benefits of its shortened format. These findings have significant implications for the study of observational pain assessment tools for older persons with dementia, as they suggest that removal of non-pain-specific items and addition of more pain-specific items may increase the tools' ability to identify pain. Moreover, it is hoped that the shorter tool will increase the probability of successful implementation of permanent evidence-based pain assessment protocols in LTC, thereby facilitating the complex pain management decision making in LTC. 3 
